YBX1 and medulloblastoma: A recent report showed that YBX1 supports immune evasion in hepatocellular carcinoma cells by decreasing the release of important inflammatory cytokines such as IL10 and TGFβ [51], further underlining our findings of a negative regulation of apoptosis-related cytokines and chemokines in medulloblastoma.